Literature DB >> 3154678

Beneficial effects of verapamil during metabolic acidosis in isolated perfused rat hearts.

W Markiewicz1, S S Wu, R Sievers, W W Parmley, T A Watters, T L James, C B Higgins, J Wikman-Coffelt.   

Abstract

Metabolic acidosis was produced in two groups of isolated, glucose-perfused beating rat hearts. The first group (control) was untreated whereas the second group was pretreated for 48 h by the addition of verapamil (1.2 g/L) to the drinking water. Untreated hearts all developed asystole during a 30 min perfusion with an acidotic substrate (pH = 6.8) or during subsequent reequilibration with physiologic substrate (pH = 7.4). Prior to asystole, all untreated hearts showed evidence of severe mechanical and biochemical deterioration evaluated by 31 P NMR spectroscopy. In contrast, hearts of treated rats showed less mechanical and metabolic deterioration, and all recovered during reequilibration. The mechanism of protection of verapamil against the effects of metabolic acidosis is unclear but appears to be related to preserved mitochondrial function by the drug and not to a reduced demand for energy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154678     DOI: 10.1007/bf02125732

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  32 in total

1.  Effect of extracellular pH on function and metabolism of isolated perfused rat heart.

Authors:  L Opie
Journal:  Am J Physiol       Date:  1965-12

2.  Extracellular pH and tension during ischemia in the isolated rabbit ventricle.

Authors:  G S Couper; J Weiss; B Hiltbrand; K I Shine
Journal:  Am J Physiol       Date:  1984-12

3.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

Authors:  W G Nayler; R Ferrari; A Williams
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

4.  Influence of low extracellular pH upon the Ca inward current and isometric contractile force in mammalian ventricular myocardium.

Authors:  M Kohlhardt; K Haap; H R Figulla
Journal:  Pflugers Arch       Date:  1976-10-15       Impact factor: 3.657

5.  Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischemic dog heart.

Authors:  N Davenport; R E Goldstein; R Bolli; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1984-04       Impact factor: 24.094

6.  Mechanism of protection by verapamil and nifedipine from anoxic injury in isolated cardiac myocytes.

Authors:  J Y Cheung; A Leaf; J V Bonventre
Journal:  Am J Physiol       Date:  1984-03

7.  The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium.

Authors:  P D Bourdillon; P A Poole-Wilson
Journal:  Circ Res       Date:  1982-03       Impact factor: 17.367

8.  The cardiac cycle: regulation and energy oscillations.

Authors:  J Wikman-Coffelt; R Sievers; R J Coffelt; W W Parmley
Journal:  Am J Physiol       Date:  1983-08

9.  Effect of verapamil on pH of ischemic canine myocardium.

Authors:  R M Watson; D R Markle; D A McGuire; D Vitale; S E Epstein; R E Patterson
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

10.  Cardiomyopathic and healthy acidotic hamster hearts: mitochondrial activity may regulate cardiac performance.

Authors:  J Wikman-Coffelt; R Sievers; W W Parmley; G Jasmin
Journal:  Cardiovasc Res       Date:  1986-07       Impact factor: 10.787

View more
  2 in total

1.  Hydrodynamics in the heart modulates work.

Authors:  T A Watters; A Bouchard; S T Wu; W W Parmley; J Wikman-Coffelt
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

2.  Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.

Authors:  Krisztina Kovacs; Katalin Hanto; Zita Bognar; Antal Tapodi; Eszter Bognar; Gyongyi N Kiss; Aliz Szabo; Gabor Rappai; Tamas Kiss; Balazs Sumegi; Ferenc Gallyas
Journal:  Mol Cell Biochem       Date:  2008-10-31       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.